Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

XKON/446440 stock hub

XKON/446440 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

XKON/446440is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

42B

Korea New Exchange

Market data

Live price

Current market quote for this ticker.

Current price

XKON/446440

In the news

Latest news · XKON/446440

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-62.7

P25 n/aP50 n/aP75 n/a

ROIC-29.3

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All XKON/446440 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

133

Groups with data

Currency

KRW

Showing 133 of 133 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	South Korea
Country code	KR
Exchange	Korea New Exchange
Financial currency	KRW
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	KRW 42B
Price	KRW 18,200
Price currency	KRW
Sic	2836
Symbol	xkon/446440
Website	https://epibiotech.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-12.05%
FCF yield	-12.2%
P/B ratio	6.66x
P/S ratio	93.38x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	60.55%
Gross Profit	KRW 272.2M
Net Income	KRW -5.1B
Pretax Margin	-1,124.91%
ROA	-28.39
ROCE	-76.75
ROE	-62.73
ROIC	-29.34

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	74.4%
Revenue Growth	15.93x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	KRW 0.04
Assets	KRW 9.3B
Cash	KRW 3.5B
Current Assets	KRW 3.7B
Current Liabilities	KRW 2.7B
Debt	KRW 2.6B
Debt Equity	KRW 0.42
Debt FCF	KRW -0.51
Equity	KRW 6.3B
Interest Coverage	-55.08
Liabilities	KRW 3B
Long Term Assets	KRW 5.6B
Long Term Liabilities	KRW 259.8M
Net Cash	KRW 851.5M
Net Cash By Market Cap	KRW 2.03
Net Debt Equity	KRW -0.14
Tangible Book Value	KRW 5.3B
Tangible Book Value Per Share	KRW 3,102
WACC	7.75

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.37
Inventory Turnover	14.21
Net Working Capital	KRW -48.4M
Quick ratio	1.29
Working Capital	KRW 1B

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	74.33%
200-day SMA	14,489
50-day SMA	14,424.4
50-day SMA vs 200-day SMA	50under200
All Time High	30,000
All Time High Change	-39.33%
All Time High Date	2023-07-31
All Time Low	8,110
All Time Low Change	124.41%
All Time Low Date	2024-08-02
ATR	1,092.3
Beta	0.69
Beta1y	0.83
Beta2y	0.21
Ch YTD	21.33
High	18,200
High52	19,000
High52 Date	2025-11-13
High52ch	-4.21%
Low	13,600
Low52	9,600
Low52 Date	2025-06-20
Low52ch	89.58%
Ma50ch	26.18%
Price vs 200-day SMA	25.61%
RSI	85.29
RSI Monthly	55.94
RSI Weekly	71.72
Sharpe ratio	1.13x
Sortino ratio	2.15
Tr YTD	21.33
Tr1m	34.92%
Tr1w	22.15%
Tr3m	30%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	KRW -5B
Operating margin	-1,120.6

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,019,696%
Net Borrowing	-66,720,000
Shares Insiders	36.94%
Shares Institutions	0.32%
Shares Out	2,306,879

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	KRW -5.1B
Average Volume	281.35x
Bv Per Share	3,313.8
CAPEX	KRW -699.4M
Ch1m	34.92
Ch1w	22.15
Ch1y	74.33
Ch3m	30
Ch6m	15.7
Change	13.82%
Change From Open	13.82
Close	15,990
Days Gap	0
Depreciation Amortization	743,986,480
Dollar Volume	10,028,200
EBIT	KRW -5B
EBITDA	KRW -4.3B
EPS	KRW -2,966
F Score	1
FCF	KRW -5.1B
FCF Per Share	KRW -2,221
Financing CF	1,535,842,300
Fiscal Year End	December
Founded	2,015
Investing CF	3,282,966,490
Is Primary Listing	1
Ma150	14,996.1
Ma150ch	21.36%
Ma20	14,948.5
Ma20ch	21.75%
Net CF	393,915,560
Open	15,990
Position In Range	100
Ppne	4,984,962,200
Price Date	2026-05-08
Ptbv Ratio	7.94
Relative Volume	1.96x
Revenue	449,620,790x
Tr6m	15.7%
Volume	551
Z Score	-3.39

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does XKON/446440 pay a dividend?

Capital-return profile for this ticker.

Performance

XKON/446440 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns XKON/446440?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.3%

Share of float held by funds and institutions

Insider ownership

+36.9%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

XKON/446440 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

85.3

Above 70: short-term overbought

Price vs 200-day MA

+25.6%

50/200-day relationship not available

Beta (5Y)

0.69

Less volatile than the market

Sharpe ratio

1.13

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About XKON/446440

Hub-level FAQ points readers to the deeper analysis pages.

What is the current xkon/446440 stock rating?

xkon/446440 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full xkon/446440 analysis?

The full report lives at /stocks/xkon/446440/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for xkon/446440?

The latest report frames xkon/446440 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the xkon/446440 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.